港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物醫藥B類股

485.171

+2.8150.58%

漲家數：21

跌家數：10

平家數：2

市盈率：- -

高：489.931

開：482.072

低：481.405

收：482.357

成交量：6,161.09萬

成交額：12.82億

市值：3,079.80億

流通市值：2,738.27億

資料載入中...

總覽新聞資訊

高瓴重倉的醫療器械公司，IPO首日開盤跌超30%

歌禮制藥－Ｂ(01672)股價下跌8.474%，現價港幣$9.235

阿斯达克财经

港股醫療設備及用品股震盪走高，德適-B大漲30%

兆科眼科(06622.HK)YUVEZZI滴眼液中國老花眼患者II期臨床達主要研究終點

阿斯达克财经

深交所：將歌禮制藥(01672)、曦智科技(01879)等調入深港通下的港股通標的

港股異動 | 劑泰科技-P(07666)早盤升逾15% 領升港股AI製藥板塊 AI4S商業化加速落地

禮邦醫藥-B公布H股獲納入港股通及恒生綜合指數

亞馬遜擴大 AI 機櫃拉貨，世芯、緯穎、鴻海出貨強勁

基石藥業-B(02616.HK)獲納入港股通標的證券名單

基石藥業-B(02616.HK)：公司獲納入港股通

和鉑醫藥-B(02142)：公司股份獲納入滬港通及深港通的股份名單

高盛、傑富瑞齊聲看好基石藥業-B(02616.HK)：CS2009療效信號持續增強關鍵催化劑有望密集兑現

開拓藥業-B(09939.HK)：KT-939人體長期安全性試驗順利完成

2026年國家醫保談判在北京啓動；珍視明回應滴眼液抽檢不合格事件 | 醫藥早參

每日经济新闻

港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)

康方雙抗再贏K藥！港股通創新藥熱度飆升

康諾亞-B(02162)：王閩川辭任非執行董事

康諾亞-B(02162.HK)：王閩川辭任非執行董事

百利天恒：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告

证券日报网

澤璟製藥(688266.SH)：注射用人促甲狀腺素β新適應症上市申請獲得受理

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1574/news?page=14"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":485.17123,"timestamp":1789632487194,"preClose":482.35672,"halted":0,"volume":61610930,"delay":0,"changeRate":0.005835,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":2.814514,"latestTime":"09-17 16:00:00","open":482.07187,"high":489.93134,"low":481.40475,"amount":1281540013.5,"amplitude":0.017677,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789695000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":3.604829,"peRate":160.310337,"turnoverRate":0.002293,"increases":18,"decrements":10,"flats":4,"marketCap":307980316848,"floatMarketCap":273827471128},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":489.93134,"amplitude":0.017677,"preClose":482.35672,"low":481.40475,"pbRate":"3.604829","latestPrice":485.17123,"volume":61610930,"delay":0,"open":482.07187,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":496.758,"twentyDayClose":517.015,"sixtyDayClose":440.071,"secType":"PLATE","market":"HK","turnoverRate":0.002293,"peRate":160.310337,"marketCap":307980316848,"floatMarketCap":273827471128,"timestamp":1789632487194,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":21,"down":10,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:14,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665968913","title":"高瓴重倉的醫療器械公司，IPO首日開盤跌超30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665968913","media":"直通IPO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665968913?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 11:01","pubTimestamp":1788750084,"startTime":"0","endTime":"0","summary":"然而，这家被高瓴资本重仓押注的企业，并未迎来开门红。上市首日，麦科田开盘即破发，股价报10港元/股，较发行价15.43港元大跌35.15%，总市值定格在53.86亿。值得注意的是，此次IPO未引入基石投资者。截至2026年3月31日，公司拥有320余款商业化医疗器械产品及60余款在研产品，覆盖全球逾140个国家及地区，经销商网络由2000余家经销商组成。尽管拥有强大的产业背景、稳健的基本面和明星机构背书，麦科田上市首日的股价表现依然不尽如人意。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/09/07110158370392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PTH","BK1100","HART","LNGR","MDEV","BK4127","LGHT","GDOC","AGNG","RSPH","09996","IEIH","BK1574","BK1583","FRHC","159883","IPOS","REDS","MEDX","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665954633","title":"歌禮制藥－Ｂ(01672)股價下跌8.474%，現價港幣$9.235","url":"https://stock-news.laohu8.com/highlight/detail?id=2665954633","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665954633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:35","pubTimestamp":1788748500,"startTime":"0","endTime":"0","summary":"[下跌股]歌礼制药－Ｂ(01672) 股价在上午10:35比前收市价下跌8.474%，现股价为港币$9.235。至目前为止，今日最高价为$10.57，而最低价为$9.235。总成交量为287.599万股，总成交金额为港币$2.858千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609071531/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609071531/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01672","BK1574","BK1191","01477","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191009962","title":"港股醫療設備及用品股震盪走高，德適-B大漲30%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191009962","media":"老虎快讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191009962?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:24","pubTimestamp":1788747884,"startTime":"0","endTime":"0","summary":"财联社9月7日电，港股医疗设备及用品股震荡走高，德适大涨30%，今海医疗科技涨超17%，精锋医疗、启明医疗涨6%。","market":"uk","thumbnail":"https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fd680cd945fd32917c8ece66ec685e5f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02225","159557","BK1150","BK1100","02500","02675","BK1583","02526","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665956423","title":"兆科眼科(06622.HK)YUVEZZI滴眼液中國老花眼患者II期臨床達主要研究終點","url":"https://stock-news.laohu8.com/highlight/detail?id=2665956423","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665956423?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:20","pubTimestamp":1788747600,"startTime":"0","endTime":"0","summary":"兆科眼科-B(06622.HK) 公布，公司的创新药卡巴胆碱酒石酸溴莫尼定滴眼液(YUVEZZI)于中国进行的第II期临床研究中已达到预先设定的主要研究终点。该疗法耐受性良好，且展现良好的安全性特征。公司计划与国家药品监督管理局药品审评中心进一步讨论，以推进第III期临床试验。(ha/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210624120700667_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210624120700667_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543118/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543118/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1583","BK1587","BK1574","06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665930583","title":"深交所：將歌禮制藥(01672)、曦智科技(01879)等調入深港通下的港股通標的","url":"https://stock-news.laohu8.com/highlight/detail?id=2665930583","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665930583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:57","pubTimestamp":1788746223,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月7日，深交所公告，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2026年09月07日起生效。调入歌礼制药(01672)、曦智科技(01879)、百度集团(09888)等，调出日清食品(01475)、海昌海洋公园(02255)、狮腾控股(02562)等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01672","BK1161","01879","BK1163","FLHK","BK1191","BK1515","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665539313","title":"港股異動 | 劑泰科技-P(07666)早盤升逾15% 領升港股AI製藥板塊 AI4S商業化加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2665539313","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665539313?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:43","pubTimestamp":1788745407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，剂泰科技-P早盘涨超15%，领涨AI制药概念股。截至发稿，涨12.81%，报15.59港元，成交额1.1亿港元。消息面上，上交所9月4日盘后发布通知，剂泰科技-P正式调入港股通标的证券名单，该调整将于9月7日(周一)起生效。这意味着内地投资者自此可通过沪深港通直接买卖剂泰科技，正式解锁南向资金。值得注意的是，上半年，剂泰科技NanoForge商业化成果进入集中释放期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","VXUS","QTOC","BK4585","CHAT","07666","BK1161","AGIX","BK1191","KCAI","ARTY","01477","BK4588","VTHR","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398982","title":"禮邦醫藥-B公布H股獲納入港股通及恒生綜合指數","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398982","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398982?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 08:50","pubTimestamp":1788742200,"startTime":"0","endTime":"0","summary":"模拟交易客户端礼邦医药-B公布，据港股通的相关安排及调整，公司H股获纳入港股通合资格证券名单，将自2026年9月7日（星期一）起生效。H股获纳入港股通乃基于其获纳入恒生综合指数。董事会认为，H股获纳入港股通及恒生综合指数，反映了资本市场对公司价值及长期发展前景的认可，并将有助于进一步扩大公司的投资者基础，提升H股的交易流动性。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-09-07/doc-iniqyeua9585261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","BK1161","09637","BK1191","BK1574","HSCI","159938","FLHK","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665981693","title":"亞馬遜擴大 AI 機櫃拉貨，世芯、緯穎、鴻海出貨強勁","url":"https://stock-news.laohu8.com/highlight/detail?id=2665981693","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665981693?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 08:45","pubTimestamp":1788741906,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，供应链传出，北美云端服务供应商龙头亚马逊旗下 AWS 近期扩大 AI 服务器机柜拉货，台积电、世芯-KY、纬颖、鸿海等协力厂出货动能强劲。亚马逊日前再次上修今年资本支出，从原估计 2,000 亿美元提升至 2,200 亿美元，主要用于 AI 基础建设，包括资料中心、服务器、网路设备等需求。亚马逊执行长贾西看好 AI 算力供不应求态势延续到 2027 年，甚至已看见 2028 年强劲需求。AWS 的 AI 业务与自研芯片规模已成长至 250 亿美元，维持三位数百分比成长。Annapurna Labs 客制化 ASIC 芯片大多交由台积电以 3 奈米先进制程生产。世芯是 AWS 自研 AI 芯片重要伙伴，看好本季单季营收与获利将创新高，第 4 季持续看增，3 奈米 AI 加速器需求优于先前评估，年底前可设计定案。AWS 的 ASIC AI 机柜由纬颖负责组装并供应交换机托盘，鸿海切入 CPU 托盘。鸿海轮值 CEO 蒋集恒表示，今年 ASIC 专案取得新进展，将 ASIC 服务器市占率目标设定在 40% 以上。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2287940","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU2168564149.EUR","LU0965509283.SGD","LU0788109477.HKD","AVEM","LU1066051811.HKD","LU0572940350.SGD","LU2242649171.HKD","HK0000914660.USD","LU2452424414.USD","BK4592","AZYY","LU0312595415.SGD","LU0882747503.HKD","IE0009G5SDU7.USD","IE00B3M56506.USD","LU2065170008.USD","LU2250418816.HKD","FDTX","LU2505996681.GBP","RTH","LU1935042991.SGD","LU1778281490.HKD","LU1712237335.SGD","LU0390134368.USD","SG9999014914.USD","IE000M9KFDE8.USD","LU1852331112.SGD","SG9999004303.SGD","LU0215105999.USD","LU1629891620.HKD","LU2592432038.USD","CGDG","IE0004445239.USD","LU0820561909.HKD","LU2746668461.USD","LU0384037296.USD","IE00BZ199S13.USD","LU2430703251.USD","IE00BZ1G4Q59.USD","LU2237438978.USD","TSMU","AMZY","IE0004091025.USD","LU2750360997.AUD","LU0310800379.SGD","LU1989772840.SGD","LU0359202008.SGD","LU0417517546.SGD","LU2764263039.SGD","TSMX","LU1267930490.SGD","SPWO","LU1935043023.USD","LU1815333072.USD","LU2211815571.USD","LU0345768153.USD","AIQ","LU2552382132.HKD","BAI","IE00B5TLWC47.USD","LU0267386448.USD","SGXZ44715902.SGD","IE00BJJMRY28.SGD","BK4534","LU2317271919.USD","LU2065171311.SGD","SG9999017495.SGD","LU0061475181.USD","USAW.SI","LU1023057109.AUD","LU2360108059.USD","LU1153585028.USD","BK4503","LU1244550577.SGD","LU0029864427.USD","LU1718418525.SGD","CORO","IE00BMPRXR70.SGD","LU2264538146.SGD","LU2089283258.USD","BK4527","BK1167","LU1280957306.USD","IE00BQXX3C00.GBP","LU1935043536.SGD","LU0359201612.USD","LU0889565833.HKD","LU0345770308.USD","IE00B775H168.HKD","LU0640476718.USD","LU2054465674.USD","LU0823421333.USD","ONLN","STSM","HULL","SG9999018865.SGD","LU2756315318.SGD","IE000MB6IJN5.SGD","IE00B19Z3B42.SGD","LU0072462426.USD","LU0541502299.USD","LU1429558221.USD","LU2063271972.USD","LU0719512351.SGD","IE00B3S45H60.SGD","LU1435385759.SGD","BK4612","IE00B1BXHZ80.USD","LU0320765489.SGD","LU0466842654.USD","SG9999004220.SGD","LU0683600562.USD","IE00BYQQ9H92.USD","AMZN","SGXZ51526630.SGD","BK1504","LU0345774391.USD","LU2552382058.USD","IE00BKDWB100.SGD","AMZZ","LU0130103400.USD","LU0203202063.USD","LU0742534661.SGD","LU2487616109.SGD","IE00B19Z9505.USD","LU0211328371.USD","LU0314104364.USD","LU0964807845.USD","LU0070217475.USD","LU2361045086.USD","SG9999014906.USD","LU0072461881.USD","SG9999015986.USD","LU1861559042.SGD","LU0308772762.SGD","LU1508157978.USD","LU1839511570.USD","LU2083900584.USD","LU0792757196.USD","LU2491050071.SGD","LU0265550359.USD","IE00BD6J9T35.USD","LU0097036916.USD","CHPX","LU1691799644.USD","BK4550","IE00BMPRXN33.USD","LU0823434740.USD","IE00BJTD4N35.SGD","LU0107464264.USD","LU1116320901.HKD","LU2237443978.SGD","LU1674673691.USD","LU1201861165.SGD","LU0251131958.USD","LU0162691827.USD","BK4591","LU0109391861.USD","EMC","LU0124676726.USD","03145","LU0354030438.USD","LU0354030511.USD","LU2552382215.SGD","LU1868837300.USD","LU0642271901.SGD","LU0289960550.SGD","LU2108987350.USD","LU2092627202.USD","LU0256863811.USD","LU0345774631.USD","LU2860962120.EUR","LU2430703095.HKD","TSMY","TINS","LU0127658192.USD","WUGI","LU1868837722.USD","LU0130102774.USD","LU2294711713.HKD","LU1868836914.USD","AVSE","ADVE","BK1508","LU1201861249.SGD","LU2381873111.SGD","LU0541501648.USD","LU2111349929.HKD","AMZU","BK4605","LU2896262040.SGD","BK4543","TSMZ","LU0345769631.USD","LU2458330243.SGD","IE00BK4W5M84.HKD","LU2023251221.USD","LU0048584097.USD","LU1267930573.SGD","IE00B4JS1V06.HKD","LU2168564222.USD","IE000WAW04H5.SGD","LU0289941410.SGD","LU2756315664.SGD","IE00B3SWFQ91.USD","LU1066051498.USD","SG9999015978.USD","IE0005OL40V9.USD","LU0154236417.USD","LU2242650005.HKD","LU0061474705.USD","LU1917777945.USD","LU1623119135.USD","LU2420271590.USD","IE000KEQY171.SGD","LU0256863902.USD","LU0070302665.USD","LU0708995401.HKD","LU1935042488.USD","LU0359201885.HKD","LU1934455194.USD","BK1574","LU0251132253.USD","LU2236285917.USD","BK4512","LU1935043452.HKD","IE0004086264.USD","IE00B19Z8X17.USD","BK4596","LU0787776722.HKD","IE0001KFT4U8.USD","LU2750360641.GBP","EMM","LU0143551892.USD","IE000F7OJYX1.SGD","LU0348723411.USD","LU1791710400.SGD","CGGO","LU2211814178.USD","LU1211504680.USD","IE00BMPRXQ63.HKD","HK0000914686.HKD","LU0238689110.USD","AMZD","LU2168564065.EUR","LU0048573561.USD","LU0096362180.USD","IE000SO60NU8.SGD","LU0980610538.SGD","LU0965509101.SGD","LU1868837565.USD","AMZP","LU0234572021.USD","SGXZ81514606.USD","LU1674673428.USD","LU2506951792.HKD","LU0316494557.USD","LU2471134952.CNY","LU1880398554.USD","LU2357305700.SGD","LU1366192091.USD","IE00BJJMRX11.SGD","LU2249611893.SGD","LU1037948897.HKD","LU2092937148.SGD","BK4559","LU0572939691.SGD","LU0096364046.USD","LU0198837287.USD","LU0456855351.SGD","LU0061474960.USD","IE00B7SZLL34.SGD","LU2077746001.SGD","IE00B775SV38.USD","CLIX","IE00BQXX3F31.USD","LU0949170426.SGD","LU1267930730.SGD","LU0170899867.USD","IE00BKVL7J92.USD","BK4561","BK4554","LU2265009873.SGD","SGXZ31699556.SGD","LU0965509010.AUD","LU0077335932.USD","LU0082616367.USD","LU2087625088.SGD","LU0323591593.USD","IE000YTNTUN2.SGD","LU1244550494.USD","LU0878004406.USD","LU0823414551.USD","LU2361044865.SGD","SGXZ80539844.SGD","LU1066053197.SGD","IE00B1XK9C88.USD","LU2764263203.CNY","LU2168564495.EUR","IE00BFSS8Q28.SGD","LU1868838027.USD","SG9999015952.SGD","LU0943347566.SGD","LU0786609619.USD","LU0648001328.SGD","LU0234570918.USD","SG9999000418.SGD","CNEQ","LU1791710582.SGD","LU0823421416.USD","TSM","LU2362540622.SGD","LU2462591350.SGD","LU0265550946.USD","LU1119994496.HKD","LU2023250843.SGD","SG9999018857.SGD","LU0158827948.USD","AMZO","LU0175139822.USD","IE000BZT7R73.USD","LU1244550221.USD","BK4598","TEK","HK0000304797.USD","LU0689472784.USD","ILDR","LU2461242641.AUD","AMZG","LU1282649067.USD","LU1046421795.USD","LU0174119429.USD","LU2746668974.SGD","LU1861127337.USD","LU1868836757.USD","LU2211817866.USD","02038","LU0053666078.USD","LU1861558580.USD","LU1868837136.USD","LU0878005551.USD","LU1934455863.HKD","LU1127390331.HKD","LU2213496289.HKD","LU2028103732.USD","BK4602","LU2237443622.USD","LU1633808545.USD","LU2247934214.USD","BK4220","LU2023250504.SGD","LU1069344957.HKD","LU0210528500.USD","LU2106854487.HKD","LU2357125470.USD","BK4533","LU0345769128.USD","BK4548","LU2092937221.SGD","BK1100","BK4524","LU2298321311.HKD","LU2471134879.HKD","LU2097829019.USD","CGNG","OGIG","LU2360032135.SGD","SAMZNmain","LU0648000940.SGD","KNOW","LU2999663052.SGD","LU1035775433.USD","IE000ITXATA3.USD","BLOX","LU0488056044.USD","LU0784385170.HKD","LU2602419157.SGD","LU0210536198.USD","TWSC","LU1084165304.USD","BK4581","LU2403377893.USD","LU1074936037.SGD","LU2133065610.SGD","LU0820561818.USD","LU1720051108.HKD","SPTE","IE00BFSS7M15.SGD","LU2125154778.USD","LU0276348264.USD","TTEQ","LU0708994859.HKD","IE000W1ABFV2.USD","LU0210533765.USD","LU0871640123.AUD","LU0823414478.USD","LU0985320562.USD","LU0157215616.USD","AMZW","LU1988902786.USD","BK4579","LU1323610961.USD","HK0000532082.HKD","BK4505","LU0251142724.SGD","LU0724617625.USD","LU2491049909.HKD","TSMG","IE00B19Z3581.USD","ESIM","LU2237443382.USD","LU0208291251.USD","BK1587","IE0004445015.USD","LU0784384876.USD","LU1496350502.SGD","LU2637965513.SGD","IE0002270589.USD","LU2430703178.SGD","LU2456880835.USD","LU0143863198.USD","SGXZ99366536.SGD","LU1048588211.SGD","BK4538","IE00BJLML261.HKD","LU1064131342.USD","LU0072462343.USD","LU2462591277.SGD","BK4535","LU2462157665.USD","LU0494093205.USD","SG9999001077.SGD","LU1814569148.SGD","LU0138981039.USD","SMH","LU0203201768.USD","LU0302445910.USD","LU0094547139.USD","LU1037948541.HKD","LU2065171402.SGD","LU0080751232.USD","LU1235294995.USD","SG9999002224.SGD","BK4551","LU2275660780.HKD","LU2065169927.USD","LU0957791311.USD","LU0672654240.SGD","LU1496350171.SGD","LU2463028550.USD","BK4532","LU0820562030.AUD","CGIC","LU0882574139.USD","LU1935042215.USD","BK4566","LU1316542783.SGD","BK4141","BK4588","LU2471134523.USD","LU2087621335.USD","LU2023250330.USD","LU2491050154.USD","LU0345768740.USD","IE0009356076.USD","LU1979441026.SGD","IE00BQXX3D17.EUR","LU2089284900.SGD","LU1145028129.USD","IE00BK4W5L77.USD","LU0320765059.SGD","IE0000B7K699.USD","LU0345770993.USD","LU0823434583.USD","LU2471134796.USD","LU0310799852.SGD","LU1066051225.USD","LU1804176565.USD","LU0011850046.USD","LU2362541273.HKD","SGXZ23171101.USD","LU0143863784.USD","SG9999014880.SGD","LU0353189763.USD","LU2168563687.JPY","LU0784385840.USD","LU1880398471.USD","LU2663582299.SGD","LU2362541513.USD","LU2543165471.USD","LU1366333091.USD","LU2041044095.USD","LU2764262908.HKD","IE00B7KXQ091.USD","LU1301847155.USD","BK4122","LU0109392836.USD","LU0861579265.USD","LU2361044949.HKD","LU2125154935.USD","IE00BWXC8680.SGD","HK0000304805.HKD","LU1261432733.SGD","LU0079474960.USD","LU0353189680.USD","LU0264606111.USD","LU1551013342.USD","SG9999015945.SGD","AMAA","LU1116320737.USD","LU1914381329.SGD","UMMA","LU0158827781.USD","LU1934455277.USD","LU0133085943.USD","FXCNY","LU1282649810.SGD","LU1823568750.SGD","IE00BJTD4V19.USD","IE00B5949003.HKD","LU1989772923.USD","LU2505996509.AUD","LU0342679015.USD","LU0128525929.USD","IE0034235303.USD","LU2237957811.SGD","SG9999014898.SGD","LU0784383803.USD","ASIA","LU2720916845.USD","LU0889566641.SGD","GB00BDT5M118.USD","LU0149725797.USD","LU0528227936.USD","LU1548497426.USD","CWI","LU0056508442.USD","LU0823411888.USD","LU2458330169.SGD","BK4604","LU1803068979.SGD","LU0965508806.USD","LU1232071149.USD","IE00B4YYXB79.USD","BK4585","LU0689626769.HKD","LU1974910355.USD","LU1989764664.SGD","LU1868836591.USD","LU2360106780.USD","IE00BKPKM429.USD","LU2237443549.SGD","LU1989764748.USD","LU2326559502.SGD","06669","IE0003U64NQ7.SGD","LU0211327993.USD","BK4526","AVXC","LU1551013425.SGD","LU2271345857.HKD","LU2237957902.USD","IE00B19Z8W00.USD","LU2417539215.USD","MEMX","LU2954938101.SGD","SG9999002232.USD","LU1267930813.SGD","WANT","IE00BN29S564.USD","BK4507","IE00BHPRN162.USD","IE00BFXG0V08.USD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665398386","title":"基石藥業-B(02616.HK)獲納入港股通標的證券名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2665398386","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665398386?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 08:32","pubTimestamp":1788741157,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02616","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665338398","title":"基石藥業-B(02616.HK)：公司獲納入港股通","url":"https://stock-news.laohu8.com/highlight/detail?id=2665338398","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665338398?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 08:27","pubTimestamp":1788740821,"startTime":"0","endTime":"0","summary":"格隆汇9月7日丨基石药业-B(02616.HK)发布公告，公司发行并于香港联交所上市的股份获纳入港股通标的证券名单，自2026年9月7日起生效。\r\n\r\n　　基石药业首席执行官、研发总裁及执行董事杨建新博士表示：“本次成功获纳入港股通标的证券名单，充分彰显了资本市场对本公司创新实力与长期发展潜力的高度认可。本次纳入有望进一步丰富本公司投资者结构，提升本公司股票在二级市场的流动性。展望未来，基石药业将持续推动核心资产的全球开发，凭借高效的管线推进与商业化布局，夯实核心竞争力，为广大投资者创造长期、可持续的价值回报。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02616","FLHK","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665602733","title":"和鉑醫藥-B(02142)：公司股份獲納入滬港通及深港通的股份名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2665602733","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665602733?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 08:17","pubTimestamp":1788740238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，自2026年9月7日起，本公司股份获纳入沪港通及深港通的股份名单，中国内地的合资格投资者可透过沪港通及深港通计划直接投资股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492542.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","02142","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665360401","title":"高盛、傑富瑞齊聲看好基石藥業-B(02616.HK)：CS2009療效信號持續增強 關鍵催化劑有望密集兑現","url":"https://stock-news.laohu8.com/highlight/detail?id=2665360401","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665360401?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 08:02","pubTimestamp":1788739364,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","BK1161","02616"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665601053","title":"開拓藥業-B(09939.HK)：KT-939人體長期安全性試驗順利完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2665601053","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665601053?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 08:01","pubTimestamp":1788739288,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09939","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665367071","title":"2026年國家醫保談判在北京啓動；珍視明回應滴眼液抽檢不合格事件 | 醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2665367071","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665367071?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 07:01","pubTimestamp":1788735712,"startTime":"0","endTime":"0","summary":"丨2026年9月7日星期一丨NO.12026年国家医保谈判在北京启动9月5日，2026年国家医保目录谈判竞价和商保创新药目录价格协商在北京启动，预计持续4至5天。新版目录有望于11月底前公布，2027年1月1日起执行。与往年相比，今年国谈整体提前约一个月，已有59个创新药完成参考药预沟通，并新增创新药“预申报”。点评：预沟通与预申报缩短创新药准入周期，有利于药企加快商业化节奏。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866183218.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866183218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","APXH","09939","XLVI","PBPH","BMED","BK1574","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665836774","title":"港股概念追蹤 | 創新藥賽道持續升温 AI提效向臨床縱深推進(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665836774","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665836774?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 06:53","pubTimestamp":1788735233,"startTime":"0","endTime":"0","summary":"西湖大学生命科学学院教授黄晶表示，AI辅助新药研发已不止于概念，而真正可以支撑原创药物从发现走向临床，直至上市。艾普司韦是西湖大学首款完全自主研发的1类创新药，用于成人轻型、中型新型冠状病毒感染的治疗。中国AI制药市场规模2025年已突破6亿元。从经营数据来看，AI相关业务正成为部分企业订单和收入增长的重要驱动力；与此同时，下游药企也在积极拥抱AI，研发提效成果逐步显现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492510.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","BK1617","BK1191","IBBQ","BK1161","AGIX","02196","LNGR","ARTY","06978","AIPO","CHAT","BK1141","VTHR","BK4585","BK1515","QTOC","03696","KCAI","BK4588","VXUS","MEDX","BK1593","02228","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364125","title":"康方雙抗再贏K藥！港股通創新藥熱度飆升","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364125","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364125?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 19:16","pubTimestamp":1788693360,"startTime":"0","endTime":"0","summary":"港股通创新药终于动起来了，9月4日，板块放量三连涨，100%创新药研发标的——港股通创新药ETF华宝成功收复年线外的所有均线。港股通创新药板块受何驱动，新一轮行情开始启动了？以100%布局创新药的港股通创新药ETF华宝为例，其覆盖的48家创新药研发类公司中，31家上半年实现盈利，其中6家同比扭亏为盈，归母净利同比正增长的多达33家，占比近七成。文中提及个股在恒生港股通创新药精选指数中的权重占比情况见配图。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-09-06/doc-iniqwwys9986173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0634319403.HKD","LU0540923850.HKD","LU1794554557.SGD","LU2476274308.USD","LU2476274720.SGD","LU0417516902.SGD","IE00BPRC5H50.USD","LU2399975544.HKD","LU1961090484.USD","LU1720050803.USD","LU0348827113.USD","BK1161","BK1574","LU2778985437.USD","KURE","09926","520880","LU0348783233.USD","LU0348784397.USD","IE00B5MMRT66.SGD","LU2488822045.USD","LU0348766576.USD","LU0561508036.HKD","LU0348825331.USD","LU0417516738.SGD","LU0417516571.SGD","LU0348767384.USD","IE00B543WZ88.USD","LU0348735423.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665646113","title":"康諾亞-B(02162)：王閩川辭任非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2665646113","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665646113?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 18:42","pubTimestamp":1788691337,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康诺亚-B(02162)发布公告，王闽川博士已递交辞呈，辞去公司非执行董事职务，自2026年9月4日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02162","BK1161","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364619","title":"康諾亞-B(02162.HK)：王閩川辭任非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364619","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364619?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 18:42","pubTimestamp":1788691337,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02162","BK1583","BK1161","BK1587","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665709364","title":"百利天恒：關於參加科創板2026年半年度創新藥行業集體業績説明會的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2665709364","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665709364?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 18:31","pubTimestamp":1788690660,"startTime":"0","endTime":"0","summary":"证券日报网讯9月6日，百利天恒发布公告称，公司计划于2026年9月16日15：00-17：00参加科创板2026年半年度创新药行业集体业绩说明会，就投资者关心的问题进行交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-06/doc-iniqwwyu6754784.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-06/doc-iniqwwyu6754784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688506","BK0239","LNGR","91194","BK1574","IBBQ","159992","BK1161","06978","MEDX","KSTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665361627","title":"澤璟製藥(688266.SH)：注射用人促甲狀腺素β新適應症上市申請獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2665361627","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665361627?lang=zh_tw&edition=fundamental","pubTime":"2026-09-06 15:36","pubTimestamp":1788680173,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泽璟制药(688266.SH)发布公告，近日，公司收到国家药品监督管理局核准签发的《受理通知书》，公司递交的注射用人促甲状腺素β(曾用名：注射用重组人促甲状腺激素，商标：泽速宁®)新适应症上市申请获得受理，本次获得受理的适应症是用于无远处转移的分化型甲状腺癌患者甲状腺全切或近全切除术后协同放射性碘(131I)清除残余甲状腺组织的治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01477","688266","BK1191","BK1574","IPOS","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":14,"totalSize":327,"code":"91000000","status":"200"}]}}